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Abstract: Persea Americana Mill (Lauraceae), is a popular plant in Cuba due to its nutritional and medicinal properties. The fruit of the 
plant is commonly known as avocado. The leaves of Persea americana Mill have been popularly used in the treatment of diabetes in 
countries in Latin America and Africa. The present study is aimed to explore one of the underlying mechanisms that mediate the antidiabetic 
efficacy of Persea americana Mill. The aqueous extract from the leaves of the plant and its fractions were evaluated on the inhibitory 
activity of the protein tyrosine phosphatase 1B (PTP1B) as target of type 2 diabetes. The results revealed that aqueous extract from P 
americana inhibited the enzymatic activity of PTP1B in an extract concentration dependent manner, resulting mainly active the most polar 
fraction. The present research demonstrated that aqueous extract from P americana and polar fraction (PaF10) have promissory antidiabetic 
properties mediated by PTP1B, which is a relevant mechanism involved on insulin resistance in type 2 diabetes. 
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Resumen: Persea americana Mill. (Lauraceae), es una planta popular en Cuba, debido a sus propiedades nutricionales y medicinales. El 
fruto de la planta se conoce comúnmente como aguacate. En la etnomedicina las hojas de Persea americana Mill. se han utilizado 
popularmente en el tratamiento  de la diabetes en varios países en Latinoamérica y África. El presente estudio tuvo el objetivo de explorar la 
eficacia antidiabética y el mecanismo subyacente, de las hojas de Persea americana. El extracto acuoso de las hojas de la planta y sus 
fracciones, se evaluaron en un blanco terapéutico de interés en la de diabetes tipo 2: actividad enzimática de la proteína tirosina fosfatasa 1B 
(PTP1B). Los resultados revelaron que el extracto acuoso de P americana  inhibe la actividad enzimática de la enzima PTP1B en una 
manera dependiente de la concentración, resultando más activa la fracción de mayor polaridad. La presente investigación demostró que el 
extracto acuoso de P americana y su fracción polar (PaF10), poseen efecto antidiabético promisorio, debido al efecto inhibitorio de PTP1B, 
mecanismo relevante en la insulino resistencia en la diabetes tipo2. 
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ABREVIATIONS LIST:  
PTP1B- protein tyrosine phosphatase 1B- 
 
INTRODUCTION  
Diabetes mellitus is a metabolic disorder of multiple 
etiologies characterized by chronic hyperglycemia and 
altered metabolism of lipids, carbohydrates and 
proteins, due to defects in insulin secretion and /or 
insulin action (ADA, 2012). Protein tyrosine 
phosphatase 1B (PTP1B) has been implicated in the 
negative regulation of insulin signaling by 
dephosphorylating the insulin receptor (IR) as well as 
its substrate, insulin receptor substrate-1 (IRS-1) and 
insulin receptor substrate-2 (IRS-2), and selective 
inhibition of PTP1B has emerged as a potential drug 
target for the treatment of type 2 diabetes (Montalibet 
and Kennedy, 2005; Teng et al., 2011). In addition to 
insulin sensitization, inhibition of PTP1B also has the 
potential to cause weight loss, which is a benefit 
because obesity is an important component of the type 
2 diabetic pathology (Delibegović and Mody, 2009). 
Persea Americana Mill. (Lauraceae), is one of 
the popular Cuban plant which is recognized by its 
nutritional and medicinal properties. The fruit of the 
plant is commonly known as avocado and constitutes 
the proper part used as food. The root, bark, fruit, and 
leaf are used extensively in traditional medicine in 
many tropical and subtropical countries for the 
treatment of various ailments (Mbang et al, 2005). In 
Nigeria, several ethnic groups use the leaves of P 
americana in the treatment of hypertension (Mbang et 
al, 2005). Cuban ethnomedicine, report some medicinal 
uses of the leaves as well: antitussive, carminative, 
anti-diarrhea, influenza, abortifacient, diuretic, 
cholagogue, depurative, spasmogenic, musculotropa, 
stomachic; indicated in cases of amenorrhea, liver 
obstructions and excess uric acid (Roig, 1988). The 
leaves of Persea americana Mill. have been popularly 
used in the treatment of diabetes in countries in Latin 
America and Africa (Lima, 2012). The aim of the study 
was to investigate the inhibitory effect on PTP1B of 
Persea americana Mill. leaves aqueous extract and its 
fractions as the underlying mechanism related with the 
antidiabetic potentiality of the plant, for type 2 
diabetes. 
 
MATERIALS AND METHODS 
Plant material 
Persea Americana Mill. (Lauraceae) leaves were 
collected in San José de Las Lajas, Mayabeque, Cuba. 
Plants were taxonomically authenticated by Prof. 
Fernando Franco Flores, in the Faculty of Agronomy 
at the Agriculture University of Havana, Cuba and a 
voucher specimen of the plant is stored for reference 
(Nº 01-2013) in the Herbarium of this institution for 
further reference. Fresh leaves of P americana were 
dried in a lab stove at 37° C during 96 h. The dry 
leaves were milled in fine particles of 5 mm. The plant 
extracts were obtained from powder aqueous 
extraction at 95° C for 30 min, in a 10% (w/v) relation. 
The resulting extracts were freeze dried. Dry extracts were 
reserved in suitably plastic bottles and stored in desiccators 
for future experiments. 
 
Plant aqueous extracts fractioning 
Ten fractions were obtained from P americana 
aqueous extract using Flash Cromathography System. 
It was used 500 mg of dried extract in an adsorption 
chromatography employing an analytical column 
(Isolute Flash, SI, 20g, Biotage) and as mobile phase, 
an organic solvents mixture, from low to high polarity 
(n-hexane; 1,2 di-chloro-metane; 2-butanol; methanol 
and water) purchased from Sigma-Aldrich. Elution 
was achieved using solvent gradients of 400 ml 
aliquots of n-hexane 100% (PaF1, 0.5 mg); 1,2 di-
chloro-metane 100% (PaF2, 2.7 mg); 1,2 di-chloro-
metane 75%: 2-butanol 25% (PaF3, 2.3 mg), 1,2 di-
chloro-metane 50%: 2-butanol 50% (PaF4, 1.3 mg), 
1,2 di-chloro-metane 25%: 2-butanol 75% (PaF5, 1.4 
mg), 2-butanol 100% (PaF6, 2.3 mg), 2-butanol 75%: 
methanol 25% (PaF7, 13.5 mg), 2-butanol 50%: 
methanol 50% (PaF8, 81.6 mg), 2-butanol 25%: 
methanol 75% (PaF9, 52.5 mg) and methanol 50%: 
water 50 % (PaF10, 88.6 mg). 
 
Protein tyrosine phosphatase 1B (PTP1B) enzyme 
assay. 
The assay was achieved as previously was described 
(Montalibet et al., 2005). The experiments were 
performed on 96 micro well plates. PTP1B (human, 
recombinant) was purchased from Sigma. For 
inhibition assay 25 l of different concentrations of P 
americana aqueous extracts and its fractions (0.01-300 
µg/mL) were evaluated. The standard inhibitor [Bis(4-
Trifluoromethylsulfonamidophenyl)-1,4-diisopropyl-
benzine] (TFMS, Calbiochem) (0.1-300 µM) or buffer 
solution (pH = 7.2), containing the following reactives 
from Sigma at final concentrations indicated: Hepes 
(25 mM), sodium chloride (50 mM), Dithiothreitol (2 
mM), ethylene-diamine-tetraacetic acid (EDTA) (2.5 
mM) and Bovine Serum Albumin (BSA) (0.01 
mg/ml), were preincubated with 50 µl of enzyme for 
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30 min at 37º C. After 25l of substrate (6, 8-difluoro-
4-methylumbelliferyl phosphate) (DiFMUP, Invitro-
gen), at final concentration of 10 M, was added to 
reaction mixture and it was placed in a 37º C incubator 
for 10 min. The amount of end product obtained was 
estimated by measuring the fluorescence changes 
using an excitation wavelength of 360 nm and an 
emission wavelength of 460 nm. 
 
Statistical analysis 
The results were analysed using the Software 
GraphPad Prism version 4.03, 2005 (La Jolla, 
California, USA). Data expressed as mean ± SEM for 
4 replicates of the experiments. 
RESULTS 
Effect of Persea americana Mill. aqueous extract on 
PTP1B enzymatic activity. 
P americana aqueous extract inhibited the enzymatic 
activity of PTP1B in an extract concentration 
dependent manner, reaching inhibitory values near to 
100 % to a concentration of 100 µg/ml. The Ki was 1.2 
± 0.15 µg/ml (Figure 1). 
 
 
 
 
Figure 1 
Dose response curve of P americana aqueous extract effect on PTP1B enzymatic activity expressed as 
percentage of control (100%). Values represent mean ± SE for each concentration tested. 
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Effect of Persea americana Mill. fractions obtained 
from aqueous extract on PTP1B enzymatic activity. 
Figure 2 shows that the fractions 1 and 2 produced a 
slight inhibition of PTP1B activity; while the fraction 
5 exhibited a moderate inhibition of this protein. 
Further fractions showed a potent effect on PTP1B 
enzymatic activity, resulting fractions 3 and 6, the 
most actives in this assay. The percentage of inhibition 
values in decreasing order were: F6 (99.3%), F3 
(98.9%), F9 (96.2%), F7 (95.5%), F10 (95.1%), F4 
(89.7%), F8 (89.0%), F5 (63.4%), F2 (29.4%), F1 
(16.8%). 
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Figure 2 
Screening of fractions at 100 µg/ml obtained from P americana aqueous extract as PTP1B inhibitors. Values 
are expressed as a percentage of PTP1B enzymatic activity of control (100%). Values represent mean ± SE for 
each fraction tested (n = 3) 
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Dose response curves of active fractions from 
aqueous extract of Persea americana Mill. on PTP1B 
enzymatic activity 
The Figure 3 (A, B, C, D, E, F and G) shows dose-
response curves of the more active fractions, obtained 
from the aqueous extract of P americana leaves on 
enzymatic activity of PTP1B. The shape of the curves 
are similar in all cases with a mean Hill slope value of 
-2.48 ± 0.53. The graphics show that PTP1B inhibitory 
activity increased in a dependent manner according to 
the concentration of the fractions, reaching inhibition 
values equal or close to 100% at the maximum 
concentration tested (300 µg/ml). Differences were 
found in the Ki values among different fractions. 
Fraction 10 showed a Ki = 1.2 ± 0.06
 
µg/ml,
 
which is 
indicative that this fraction was the most effective in 
the inhibition of PTP1B activity. 
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Figure 3 
Dose response curves of active fractions PaF4 (A), PaF5 (B), PaF6 (C), PaF7 (D), PaF8 (E), PaF9 (F) and PaF10 
(G) from P americana leaves aqueous extract on PTP1B enzymatic activity expressed as percentage of control 
(100%). Values represent mean ± SE for each concentration tested. 
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DISCUSSION 
The leaves of Persea americana Mill. (Lauraceae) 
have been popularly used in the treatment of diabetes 
in countries in Latin America and Africa (Lima et al., 
2012). It was also reported that the aqueous leaf 
extract of P americana possesses hypoglycemic effects 
in the normal rats. The maximum antidiabetic activity 
was reached at 6 h after a single dose of the extract 
was administered, producing 60.02 ± 6.83% reduction 
in blood glucose level (Anita et al., 2005). 
The present study was approached to explore 
the possible mechanism, mediated by PTP1B enzyme 
inhibition, which could be underlying the P americana 
antidiabetic activity observed in ethnomedicine (Lima 
et al., 2012). Protein tyrosine phosphatase 1B (PTP1B) 
has been implicated in the negative regulation of 
insulin signaling by dephosphorylating the insulin 
receptor (IR) as well as its substrate, insulin receptor 
substrate-1 (IRS-1) and insulin receptor substrate-2 
(IRS-2), so according to that selective inhibition of 
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PTP1B has emerged as a potential drug target for the 
treatment of type 2 diabetes (Teng et al., 2011). 
A phytopharmacological review on Persea 
Americana showed that avocados are a rich source of 
nutrients and phytochemicals as well (Yasir et al., 
2010). Major chemical constituents of the different 
parts of the plant of P. americana Mill. has been 
reported (Ding et al., 2007). The compounds classes 
were separated into aliphatic acetogenins or alkanols 
(del Refugio et al., 2004), terpenoid glycosides 
(Rodriguez et al., 1999), various furan ring-containing 
derivatives (Werman and Neeman, 1990) and 
flavonoids (Litz et al., 2005). The highly 
functionalized alkanols (1-17) of avocado have 
exhibited quite diverse biological properties 
(Kawagishi et al., 2001). 
In our study most PTP1B inhibitory activity 
was found in P. americana more polar fraction, 
corresponding with fraction PaF10. This fraction 
might probably contain tannins, although further 
experiments on chemical characterization of this 
fraction will be necessary to demonstrate it. It has been 
confirmed the importance of tannins in the PTP1B 
inhibitory effect, comparing results of total methanolic 
extract and detanificated extract of Cichorium intybus 
demonstrated that tannins are responsible components 
of this pharmacological effect (Muthusamy et al., 
2008). Other plant extracts have showed inhibitory 
effect on PTP1B enzymatic activity in the same range 
of concentrations of P. americana leaves, evaluated in 
the present work. Thus, the methanolic extract of 
Psidium guajava was reported to have a significant 
inhibitory effect of 87%, at a concentration of 30 
μg/mL, resulting, after the extract fractionation into 
four sub-fractions by solvent partition, butanol fraction 
as the active fraction with an IC50 value of 2.6 μg/ml 
(Oh et al., 2005). Other constituents have been also 
reported with that activity, for example terpenoids 
compounds (Yu et al., 2005; Thuong et al., 2008). 
Thus, it is possible that terpenoid glycosides could 
contribute to PTP1B inhibitory effect in the total 
extract and it can be presents in other evaluated 
fractions. 
Previous studies have shown that PTP1B 
enzyme has two active sites: a catalytic site and an 
allosteric site. By X-ray diffraction have been 
identified the interactions between PTP1B and 
allosteric inhibitors (Lee et al., 2008). A general 
mechanism proposed for other proteins tyrosine 
phosphatases, is that allosteric inhibitors prevent the 
formation of the enzyme active form, blocking the 
WPD loop mobility in the catalytic site, which closure 
is essential for catalytic activity of the enzyme 
(Wiesmann et al., 2004). Hansen et al., 2005 reported 
that the allosteric inhibition of PTP1B activity can be 
achieved by selective modification of cysteine 
residues, Cys 121, which although is not located in the 
catalytic site, providing interactions with residues 
which are in contact with the His 214, which has been 
shown to be important for catalysis. Thus, the 
amentoflavone obtained from Selaginella tamariscina, 
a biflavonoide, inhibited PTP1B activity by allosteric 
inhibition (Lee et al., 2008). 
Previous studies has confirmed that the 
hydroalcoholic extract of the leaves of Persea 
americana has anti-diabetic properties and possibly 
acts to regulate glucose uptake in liver and muscles by 
way of PKB/Akt activation, restoring the intracellular 
energy balances (Lima et al., 2012). Other authors 
evaluated the insulin-stimulative and anti-oxidative 
effects of Persea americana fruit extract using 
streptozotocin (STZ) rats model. After the treatment 
with avocado fruit extract, the elevated levels of blood 
glucose, glycosilated haemoglobin, blood urea and 
serum creatinine seen in the hyperglycaemic rats, 
reverted back to near normal. Determination of 
thiobarbituric acid reactive substances (TBARS), 
hydroperoxides and enzymatic and non-enzymatic 
antioxidants, confirmed the anti-oxidative potential of 
avocado fruit extract which, in turn, might be 
responsible for its hypoglycaemic potential. 
(Mahadeva and Adinew, 2011). 
 
CONCLUSION 
The present research showed that aqueous extract of P. 
americana Mill. leaf has PTP1B inhibitory activity 
that explain in part the mechanism underlying the 
antidiabetic effect. The more polar fraction (PaF10) 
showed the best inhibitory enzymatic activity. Future 
experiments are needed to clarify the chemical 
structures responsible of such biological activity. 
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